Previous research indicated that SalA may protect against peripheral immune cell infiltration after ischemic stroke by inhibition of the CD11b/CD18 complex, intercellular adhesion molecule-1 (ICAM-1), soluble epoxide hydrolase (sEH), and granulocyte adherence (42–47). Here, ICAM1 is linked to ischemic stroke.